This report analyzes the worldwide markets for Nanobiotechnology in US$ Million.
The major product segments analyzed are Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, and Nanotubes and Fullerenes), and Nanodevices/Tools.
The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World.
Annual forecasts are provided for each region for the period of 2000 through 2010.
The report profiles 91 companies including many key and niche players worldwide such as Alnis Biosciences, Inc., American Pharmaceutical Partners, Inc., Biosante Phosphate Pharmaceuticals, Inc., Capsulution NanoScience AG, Carbon Nanotechnologies, Inc, C Sixty, Inc, Dendritic Nanotechnologies, Inc., Dendritech, Inc, Elan Pharmaceuticals, Flamel Technologies, Inc, iMedd, Inc., Nanospectra Biosciences, Inc., Nanophase Technologies Corporation, Nano-C, Inc., Nanocyl SA, Nanolab Systems Ltd, Nanosphere, Inc., Nanotherapeutics, Inc., Nanosys, Inc., PSiVida Ltd, Quantum Dot Corp, Starpharma Holdings Ltd, Sigma Aldrich Company, and Triton Biosystems, Inc.